English

ADVANCED CELL TECHNOLOGY, INC.

EDGAR

ACTC Quarterly report (10-Q) · filed 2015-11-09

80 filing records in this dataset, filed from 2001-09-12 to 2015-11-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

84.3 thousand USD

2015 Q3 · USD

Exact inputs and evidence

Revenue: 84252 USD Source

Operating margin

-8,795.71%

2015 Q3 · %

Exact inputs and evidence

Operating Income: -7410559 USD Source
Revenue: 84252 USD Source

Operating cash flow

-5.56 million USD

2015 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -19256900 USD Source
Operating Cash Flow: -13694411 USD Source

Free cash flow

-5.57 million USD

2015 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -19256900 USD Source
Operating Cash Flow: -13694411 USD Source
Capital Expenditure: 126799 USD Source
Capital Expenditure: 119846 USD Source

Cash and cash equivalents: 32.1 million USD 2015-09-30 Source
Exact value

32137535 USD
Long-term debt including current maturities: 5.69 million USD 2015-09-30 Source
Exact value

5693377 USD
Shares outstanding: 42.3 million shares 2015-09-30 Source
Exact value

42300462 shares

Reported share-count change

23.11% · 7.94 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

34358658 shares · 2014-09-30· Source
42300462 shares · 2015-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-25 million USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Net income: -6824735 USD · 2014-10-01 – 2014-12-31 Source
Net income: -7035571 USD · 2015-01-01 – 2015-03-31 Source
Net income: -7245810 USD · 2015-04-01 – 2015-06-30 Source
Net income: -3845725 USD · 2015-07-01 – 2015-09-30 Source

Operating cash flow

-24.1 million USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Operating cash flow: -21447451 USD · 2014-01-01 – 2014-12-31 Source
Operating cash flow: -16563159 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -6992040 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -13694411 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -6992040 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -19256900 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -13694411 USD · 2015-01-01 – 2015-06-30 Source

Capital expenditure

254 thousand USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Capital expenditure: 263375 USD · 2014-01-01 – 2014-12-31 Source
Capital expenditure: 135891 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 20434 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 119846 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 20434 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 126799 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 119846 USD · 2015-01-01 – 2015-06-30 Source

Free cash flow

-24.4 million USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Operating cash flow: -21447451 USD · 2014-01-01 – 2014-12-31 Source
Operating cash flow: -16563159 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -6992040 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -13694411 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -6992040 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -19256900 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -13694411 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 263375 USD · 2014-01-01 – 2014-12-31 Source
Capital expenditure: 135891 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 20434 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 119846 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 20434 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 126799 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 119846 USD · 2015-01-01 – 2015-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-11-09.

Financial data available through: 2014-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2011-12-31
Operating income: 10 of 11 periods available· newest 2014-12-31
Net income: 11 of 11 periods available· newest 2014-12-31
Operating cash flow: 11 of 11 periods available· newest 2014-12-31
Capital expenditure: 11 of 11 periods available· newest 2014-12-31
Total assets: 11 of 11 periods available· newest 2014-12-31
Total liabilities: 11 of 11 periods available· newest 2014-12-31
Current assets: 11 of 11 periods available· newest 2014-12-31
Current liabilities: 11 of 11 periods available· newest 2014-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2014-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2014-12-31
Shares outstanding: 5 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 3.73 million

Prior period

−USD 31.02 million

2013-01-01 – 2013-12-31
Current period

−USD 34.75 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-34748945 − -31022248 = -3726697 USD

-31022248 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-34748945 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ADVANCED CELL TECHNOLOGY, INC. · 2014-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Year-over-year change in Net income: -3726697 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -34748945 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#121641 Filing: 000101968715000981 Input fundies:NetIncome: -31022248 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#121769 Filing: 000101968715000981
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 517,748

Prior period

−USD 21.97 million

2013-01-01 – 2013-12-31
Current period

−USD 21.45 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-21447451 − -21965199 = 517748 USD

-21965199 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-21447451 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2014-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Year-over-year change in Operating cash flow: 517748 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -21447451 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#133838 Filing: 000101968715000981 Input fundies:OperatingCashFlow: -21965199 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#134064 Filing: 000101968715000981
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-60.8%

Prior period

USD 671,827

2013-01-01 – 2013-12-31
Current period

USD 263,375

2014-01-01 – 2014-12-31

Exact inputs and evidence

263375 − 671827 = -408452 USD

671827 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
263375 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2014-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Year-over-year change in Capital expenditure: -408452 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 263375 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#136302 Filing: 000101968715000981 Input fundies:CapitalExpenditure: 671827 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#136485 Filing: 000101968715000981
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

Revenue USD 506,419 100% of revenue
Cost of revenue USD 343,950 68% of revenue
Operating expenses USD 17.48 million 3,452% of revenue
Operating income −USD 17.32 million −3,420% of revenue
Tax, interest and other Derived USD 37.87 million 7,478% of revenue
Net income −USD 55.19 million −10,899% of revenue

Cash

Operating cash flow −USD 13.63 million −2,691% of revenue
Capital expenditure USD 36,830 7.3% of revenue
Free cash flow Derived −USD 13.66 million −2,698% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Operating loss: operating costs were 864% of revenue.
2010 Operating loss: operating costs were 4,559% of revenue.
2011 Operating loss: operating costs were 3,520% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	1415979	12238633 Derived	-10822654	25935554 Derived	-36758208	-5148146 Derived	Source 2009-01-01 – 2009-12-31: 1415979 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -10822654 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -36758208 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -5142778 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 5368 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	725044	33053675 Derived	-32328631	22044701 Derived	-54373332	-8990334 Derived	Source 2010-01-01 – 2010-12-31: 725044 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -32328631 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -54373332 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -8782932 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 207402 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	506419	17827562 Derived	-17321143	37871660 Derived	-55192803	-13664117 Derived	Source 2011-01-01 – 2011-12-31: 506419 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -17321143 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -55192803 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -13627287 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 36830 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 506.4K 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	3200	Revenue: 3200 Open source
20092009-12-31	Revenue	1415979	Revenue: 1415979 Open source
20102010-12-31	Revenue	725044	Revenue: 725044 Open source
20112011-12-31	Revenue	506419	Revenue: 506419 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-30.2% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 3200 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 1415979 Open source
20102010-12-31	Year over year	-48.8%	Revenue: 725044 Open source Revenue: 1415979 Open source
20112011-12-31	Year over year	-30.2%	Revenue: 506419 Open source Revenue: 725044 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3,420.3% 2011

Net margin -10,898.6% 2011

Free cash flow margin -2,698.2% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Operating margin	Not reported	Revenue: 3200 Open source
20092009-12-31	Operating margin	-764.3%	Operating Income: -10822654 Open source Revenue: 1415979 Open source
20102010-12-31	Operating margin	-4,458.9%	Operating Income: -32328631 Open source Revenue: 725044 Open source
20112011-12-31	Operating margin	-3,420.3%	Operating Income: -17321143 Open source Revenue: 506419 Open source
20042004-12-31	Net margin	-79,333.1%	Net Income: -2538659 Open source Revenue: 3200 Open source
20092009-12-31	Net margin	-2,596%	Net Income: -36758208 Open source Revenue: 1415979 Open source
20102010-12-31	Net margin	-7,499.3%	Net Income: -54373332 Open source Revenue: 725044 Open source
20112011-12-31	Net margin	-10,898.6%	Net Income: -55192803 Open source Revenue: 506419 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 3200 Open source
20092009-12-31	Free cash flow margin	-363.6%	Revenue: 1415979 Open source Operating Cash Flow: -5142778 Open source Capital Expenditure: 5368 Open source
20102010-12-31	Free cash flow margin	-1,240%	Revenue: 725044 Open source Operating Cash Flow: -8782932 Open source Capital Expenditure: 207402 Open source
20112011-12-31	Free cash flow margin	-2,698.2%	Revenue: 506419 Open source Operating Cash Flow: -13627287 Open source Capital Expenditure: 36830 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.6M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	Not reported	No source recorded
20092009-12-31	Operating cash flow	-5142778	Operating Cash Flow: -5142778 Open source
20102010-12-31	Operating cash flow	-8782932	Operating Cash Flow: -8782932 Open source
20112011-12-31	Operating cash flow	-13627287	Operating Cash Flow: -13627287 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -13.7M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	Unavailable	No source recorded
20092009-12-31	Free cash flow	-5148146	Operating Cash Flow: -5142778 Open source Capital Expenditure: 5368 Open source
20102010-12-31	Free cash flow	-8990334	Operating Cash Flow: -8782932 Open source Capital Expenditure: 207402 Open source
20112011-12-31	Free cash flow	-13664117	Operating Cash Flow: -13627287 Open source Capital Expenditure: 36830 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

394.3% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Liabilities / assets	246.8%	Total Liabilities: 12764729 Open source Total Assets: 5172210 Open source
20092009-12-31	Liabilities / assets	987.9%	Total Liabilities: 50262896 Open source Total Assets: 5088008 Open source
20102010-12-31	Liabilities / assets	217.5%	Total Liabilities: 41434801 Open source Total Assets: 19054152 Open source
20112011-12-31	Liabilities / assets	394.3%	Total Liabilities: 59880044 Open source Total Assets: 15185326 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.24× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	0.6×	Current Assets: 3931213 Open source Current Liabilities: 6593681 Open source
20092009-12-31	Current assets / current liabilities	0.11×	Current Assets: 2639490 Open source Current Liabilities: 24375874 Open source
20102010-12-31	Current assets / current liabilities	1.41×	Current Assets: 15981007 Open source Current Liabilities: 11343120 Open source
20112011-12-31	Current assets / current liabilities	0.24×	Current Assets: 13406690 Open source Current Liabilities: 55749567 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	−USD 9.39 million Exact value Exact value: -9393778 USD 2005-01-01 – 2005-12-31: -9393778 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2005-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -9393778 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9393778 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001104659-07-020144.txt#12323 The citation records this snapshot. The page link may show a newer release later.	−USD 8.51 million Exact value Exact value: -8510945 USD 2005-01-01 – 2005-12-31: -8510945 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2005-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -8510945 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8510945 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001104659-07-020144.txt#12881 The citation records this snapshot. The page link may show a newer release later.	USD 603,735 Exact value Exact value: 603735 USD 2005-01-01 – 2005-12-31: 603735 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2005-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 603735 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 603735 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001104659-07-020144.txt#12943 The citation records this snapshot. The page link may show a newer release later.	−USD 9.11 million Calculation and evidence -8510945 − 603735 USD Exact free cash flow: -9114680 USD 2005-01-01 – 2005-12-31: -8510945 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 603735 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2005-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -9114680 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8510945 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001104659-07-020144.txt#12881 Input fundies:CapitalExpenditure: 603735 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001104659-07-020144.txt#12943 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 16.86 million Exact value Exact value: -16861789 USD 2006-01-01 – 2006-12-31: -16861789 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2006-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -16861789 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16861789 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6006 The citation records this snapshot. The page link may show a newer release later.	−USD 13.31 million Exact value Exact value: -13305845 USD 2006-01-01 – 2006-12-31: -13305845 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2006-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -13305845 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13305845 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6307 The citation records this snapshot. The page link may show a newer release later.	USD 564,805 Exact value Exact value: 564805 USD 2006-01-01 – 2006-12-31: 564805 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2006-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 564805 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 564805 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6335 The citation records this snapshot. The page link may show a newer release later.	−USD 13.87 million Calculation and evidence -13305845 − 564805 USD Exact free cash flow: -13870650 USD 2006-01-01 – 2006-12-31: -13305845 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 564805 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2006-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -13870650 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13305845 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6307 Input fundies:CapitalExpenditure: 564805 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6335 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 15.9 million Exact value Exact value: -15898725 USD 2007-01-01 – 2007-12-31: -15898725 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2007-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -15898725 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15898725 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6006 The citation records this snapshot. The page link may show a newer release later.	−USD 16.03 million Exact value Exact value: -16031464 USD 2007-01-01 – 2007-12-31: -16031464 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2007-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -16031464 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16031464 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6307 The citation records this snapshot. The page link may show a newer release later.	USD 158,522 Exact value Exact value: 158522 USD 2007-01-01 – 2007-12-31: 158522 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2007-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 158522 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 158522 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6335 The citation records this snapshot. The page link may show a newer release later.	−USD 16.19 million Calculation and evidence -16031464 − 158522 USD Exact free cash flow: -16189986 USD 2007-01-01 – 2007-12-31: -16031464 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 158522 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2007-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -16189986 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16031464 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6307 Input fundies:CapitalExpenditure: 158522 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001047469-08-007884.txt#6335 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 33.9 million Exact value Exact value: -33903513 USD 2008-01-01 – 2008-12-31: -33903513 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2008-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -33903513 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33903513 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001013762-11-000631.txt#12444 The citation records this snapshot. The page link may show a newer release later.	−USD 2.96 million Exact value Exact value: -2964820 USD 2008-01-01 – 2008-12-31: -2964820 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2008-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -2964820 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2964820 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001013762-11-000631.txt#12986 The citation records this snapshot. The page link may show a newer release later.	USD 174,514 Exact value Exact value: 174514 USD 2008-01-01 – 2008-12-31: 174514 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2008-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 174514 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 174514 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001013762-11-000631.txt#13032 The citation records this snapshot. The page link may show a newer release later.	−USD 3.14 million Calculation and evidence -2964820 − 174514 USD Exact free cash flow: -3139334 USD 2008-01-01 – 2008-12-31: -2964820 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 174514 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2008-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -3139334 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2964820 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001013762-11-000631.txt#12986 Input fundies:CapitalExpenditure: 174514 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/0001013762-11-000631.txt#13032 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 36.76 million Exact value Exact value: -36758208 USD 2009-01-01 – 2009-12-31: -36758208 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2009-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -36758208 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36758208 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968712003798/actc-20111231.xml#29078 Filing: 000101968712003798 The citation records this snapshot. The page link may show a newer release later.	−USD 5.14 million Exact value Exact value: -5142778 USD 2009-01-01 – 2009-12-31: -5142778 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2009-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -5142778 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5142778 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968712003798/actc-20111231.xml#26501 Filing: 000101968712003798 The citation records this snapshot. The page link may show a newer release later.	USD 5,368 Exact value Exact value: 5368 USD 2009-01-01 – 2009-12-31: 5368 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2009-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 5368 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5368 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968712003798/actc-20111231.xml#30767 Filing: 000101968712003798 The citation records this snapshot. The page link may show a newer release later.	−USD 5.15 million Calculation and evidence -5142778 − 5368 USD Exact free cash flow: -5148146 USD 2009-01-01 – 2009-12-31: -5142778 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 5368 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2009-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -5148146 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5142778 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968712003798/actc-20111231.xml#26501 Filing: 000101968712003798 Input fundies:CapitalExpenditure: 5368 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968712003798/actc-20111231.xml#30767 Filing: 000101968712003798 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 54.37 million Exact value Exact value: -54373332 USD 2010-01-01 – 2010-12-31: -54373332 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2010-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -54373332 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54373332 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968713000740/actc-20121231.xml#135828 Filing: 000101968713000740 The citation records this snapshot. The page link may show a newer release later.	−USD 8.78 million Exact value Exact value: -8782932 USD 2010-01-01 – 2010-12-31: -8782932 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2010-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -8782932 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8782932 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968713000740/actc-20121231.xml#147766 Filing: 000101968713000740 The citation records this snapshot. The page link may show a newer release later.	USD 207,402 Exact value Exact value: 207402 USD 2010-01-01 – 2010-12-31: 207402 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2010-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 207402 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 207402 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968713000740/actc-20121231.xml#149882 Filing: 000101968713000740 The citation records this snapshot. The page link may show a newer release later.	−USD 8.99 million Calculation and evidence -8782932 − 207402 USD Exact free cash flow: -8990334 USD 2010-01-01 – 2010-12-31: -8782932 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 207402 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2010-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -8990334 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8782932 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968713000740/actc-20121231.xml#147766 Filing: 000101968713000740 Input fundies:CapitalExpenditure: 207402 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968713000740/actc-20121231.xml#149882 Filing: 000101968713000740 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 55.19 million Exact value Exact value: -55192803 USD 2011-01-01 – 2011-12-31: -55192803 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2011-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -55192803 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55192803 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968714001176/actc-20131231.xml#188474 Filing: 000101968714001176 The citation records this snapshot. The page link may show a newer release later.	−USD 13.63 million Exact value Exact value: -13627287 USD 2011-01-01 – 2011-12-31: -13627287 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2011-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -13627287 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13627287 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968714001176/actc-20131231.xml#2091602 Filing: 000101968714001176 The citation records this snapshot. The page link may show a newer release later.	USD 36,830 Exact value Exact value: 36830 USD 2011-01-01 – 2011-12-31: 36830 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2011-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 36830 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36830 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968714001176/actc-20131231.xml#246033 Filing: 000101968714001176 The citation records this snapshot. The page link may show a newer release later.	−USD 13.66 million Calculation and evidence -13627287 − 36830 USD Exact free cash flow: -13664117 USD 2011-01-01 – 2011-12-31: -13627287 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 36830 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2011-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -13664117 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13627287 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968714001176/actc-20131231.xml#2091602 Filing: 000101968714001176 Input fundies:CapitalExpenditure: 36830 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968714001176/actc-20131231.xml#246033 Filing: 000101968714001176 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 34.58 million Exact value Exact value: -34584115 USD 2012-01-01 – 2012-12-31: -34584115 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2012-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -34584115 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34584115 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#122303 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	−USD 14.61 million Exact value Exact value: -14606357 USD 2012-01-01 – 2012-12-31: -14606357 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2012-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -14606357 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14606357 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#134290 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	USD 96,260 Exact value Exact value: 96260 USD 2012-01-01 – 2012-12-31: 96260 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2012-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 96260 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 96260 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#136668 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	−USD 14.7 million Calculation and evidence -14606357 − 96260 USD Exact free cash flow: -14702617 USD 2012-01-01 – 2012-12-31: -14606357 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 96260 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2012-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -14702617 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14606357 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#134290 Filing: 000101968715000981 Input fundies:CapitalExpenditure: 96260 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#136668 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 31.02 million Exact value Exact value: -31022248 USD 2013-01-01 – 2013-12-31: -31022248 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2013-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -31022248 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31022248 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#121769 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	−USD 21.97 million Exact value Exact value: -21965199 USD 2013-01-01 – 2013-12-31: -21965199 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2013-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -21965199 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21965199 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#134064 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	USD 671,827 Exact value Exact value: 671827 USD 2013-01-01 – 2013-12-31: 671827 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2013-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 671827 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 671827 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#136485 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	−USD 22.64 million Calculation and evidence -21965199 − 671827 USD Exact free cash flow: -22637026 USD 2013-01-01 – 2013-12-31: -21965199 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 671827 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2013-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -22637026 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21965199 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#134064 Filing: 000101968715000981 Input fundies:CapitalExpenditure: 671827 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#136485 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 34.75 million Exact value Exact value: -34748945 USD 2014-01-01 – 2014-12-31: -34748945 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED CELL TECHNOLOGY, INC. · 2014-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Net Income: -34748945 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34748945 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#121641 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	−USD 21.45 million Exact value Exact value: -21447451 USD 2014-01-01 – 2014-12-31: -21447451 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED CELL TECHNOLOGY, INC. · 2014-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Operating Cash Flow: -21447451 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21447451 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#133838 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	USD 263,375 Exact value Exact value: 263375 USD 2014-01-01 – 2014-12-31: 263375 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADVANCED CELL TECHNOLOGY, INC. · 2014-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Capital Expenditure: 263375 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 263375 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#136302 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.	−USD 21.71 million Calculation and evidence -21447451 − 263375 USD Exact free cash flow: -21710826 USD 2014-01-01 – 2014-12-31: -21447451 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 263375 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADVANCED CELL TECHNOLOGY, INC. · 2014-12-31 ADVANCED CELL TECHNOLOGY, INC. (edgar:1140098) Free cash flow: -21710826 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:13Z Snapshot: a9741cbf04b68e7b780e65a5daf6c125d1fb83c96462533cf5d258b23b59ad08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1140098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21447451 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#133838 Filing: 000101968715000981 Input fundies:CapitalExpenditure: 263375 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1140098/000101968715000981/ocat-20141231.xml#136302 Filing: 000101968715000981 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

80 filings · 1,377 latest values · 1,377 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001140098, 1140098, ACTC, edgar:1140098

Also known as A.C.T Holdings, Inc., A.C.T. Holdings, Inc., ADVANCED CELL TECHNOLOGY, INC., C T Holdings Inc, Ocata Therapeutics, Inc., TWO MOONS KACHINAS CORP

ADVANCED CELL TECHNOLOGY, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2011-01-01 – 2011-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation